| Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary Fibrosis (NCT07728721) | Haisco Pharmaceutical Group Co., Ltd. | 2026-08-25 |
| A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD (NCT07658339) | Haisco Pharmaceutical Group Co., Ltd. | 2026-07-11 |
| Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPD (NCT07634367) | Haisco Pharmaceutical Group Co., Ltd. | 2026-07-10 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of HSK46256 in Patients With Advanced Solid Tumors (NCT07695142) | Haisco Pharmaceutical Group Co., Ltd. | 2026-07-09 |
| HSK41959 With Standard Therapy in Solid Tumors With MTAP Deletion (NCT07699757) | Haisco Pharmaceutical Group Co., Ltd. | 2026-07-01 |
| A Phase 3 Study Evaluating the Safety and Efficacy of HSK31679 in Patients With MASH (NCT07581951) | Haisco Pharmaceutical Group Co., Ltd. | 2026-06-30 |
| First-in-human Study of HSK56630 in Healthy Subjects (NCT07580794) | Haisco Pharmaceutical Group Co., Ltd. | 2026-06-17 |
| A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD (NCT07583849) | Haisco Pharmaceutical Group Co., Ltd. | 2026-05-24 |
| A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Abdominal Surgery (NCT07533786) | Haisco Pharmaceutical Group Co., Ltd. | 2026-05-22 |
| HSK3486 (Cipepofol) Injectable Emulsion for Induction of General Anesthesia in Pediatric Subjects Undergoing Elective Surgery (NCT07510945) | Haisco Pharmaceutical Group Co., Ltd. | 2026-05-01 |
| Phase Ⅲ Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN (NCT07390123) | Haisco Pharmaceutical Group Co., Ltd. | 2026-04-07 |
| Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis (NCT07503587) | Haisco Pharmaceutical Group Co., Ltd. | 2026-04-05 |
| A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (NCT07519070) | Haisco Pharmaceutical Group Co., Ltd. | 2026-04-05 |
| A Clinical Trial Evaluating the Efficacy and Safety of HSK55718 in Patients for Postoperative Pain Treatment in Orthopedic Surgery (NCT07551739) | Haisco Pharmaceutical Group Co., Ltd. | 2026-04-01 |
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect of HSK55879 Tablets in Healthy Subjects. (NCT07521345) | Haisco Pharmaceutical Group Co., Ltd. | 2026-03-20 |
| Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation (NCT07561554) | Haisco Pharmaceutical Group Co., Ltd. | 2026-03-06 |
| Long-Term Safety and Efficacy of HSK39004 Dry Powder Inhaler in COPD (NCT07425210) | Haisco Pharmaceutical Group Co., Ltd. | 2026-03-01 |
| A Study for HSK47388 in Participants With Ulcerative Colitis (NCT07335055) | Haisco Pharmaceutical Group Co., Ltd. | 2026-02-03 |
| Study to Assess Efficacy and Safety of HSK39297 Tablets in Patients With LN (NCT07363460) | Haisco Pharmaceutical Group Co., Ltd. | 2025-11-18 |
| A Multicenter, Randomized, Open-Label, Parallel-Controlled Clinical Study Comparing the Efficacy and Safety of Cofrogliptin Versus Acarbose in Drug-Naïve Patients With Type 2 Diabetes (NCT07122102) | Haisco Pharmaceutical Group Co., Ltd. | 2025-10-01 |
| A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis (NCT07616375) | Haisco Pharmaceutical Group Co., Ltd. | 2025-09-28 |
| A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis (NCT07150988) | Haisco Pharmaceutical Group Co., Ltd. | 2025-09-26 |
| A Phase 2 Study of HSK47388 Tablets to Evaluate the Efficacy and Safety in Patients With Moderate-to-Severe Plaque Psoriasis (NCT07158268) | Haisco Pharmaceutical Group Co., Ltd. | 2025-09-01 |
| A Study to Assess PK, Safety and Efficacy of HSK47977 Tablets in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT07283796) | Haisco Pharmaceutical Group Co., Ltd. | 2025-08-28 |
| A Study to Evaluate the Long-Term Safety and Efficacy of HSK39297 Tablets in Primary IgA Nephropathy (NCT07616700) | Haisco Pharmaceutical Group Co., Ltd. | 2025-08-25 |
| Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation (NCT07158710) | Haisco Pharmaceutical Group Co., Ltd. | 2025-08-15 |
| Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT07108699) | Haisco Pharmaceutical Group Co., Ltd. | 2025-08-13 |
| Clinical Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HSK31858 in Healthy Subjects (NCT07134465) | Haisco Pharmaceutical Group Co., Ltd. | 2025-08-11 |
| Food Effect Study of HSK47388 in Healthy Subjects (NCT07192692) | Haisco Pharmaceutical Group Co., Ltd. | 2025-08-08 |
| A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD Patients (NCT07331402) | Haisco Pharmaceutical Group Co., Ltd. | 2025-07-28 |
| A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery (NCT07186426) | Haisco Pharmaceutical Group Co., Ltd. | 2025-07-28 |
| A Long-term Study of HSK44459 Tablets in Participants With Bechet's Disease (NCT07070739) | Haisco Pharmaceutical Group Co., Ltd. | 2025-07-01 |
| Long-term Safety and Efficacy Study of HSK44459 Tablets in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT07019090) | Haisco Pharmaceutical Group Co., Ltd. | 2025-06-27 |
| Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HSK39297 in Subjects With Hepatic Impairment (NCT07152288) | Haisco Pharmaceutical Group Co., Ltd. | 2025-05-29 |
| Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With Anemia (NCT07052838) | Haisco Pharmaceutical Group Co., Ltd. | 2025-05-12 |
| This Study is to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of HSK47388 in Healthy Volunteers (NCT06926218) | Haisco Pharmaceutical Group Co., Ltd. | 2025-05-01 |
| Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT07140328) | Haisco Pharmaceutical Group Co., Ltd. | 2025-04-24 |
| Phase I Study of HSK41959 in Solid Tumors With MTAP Deletion (NCT06968572) | Haisco Pharmaceutical Group Co., Ltd. | 2025-04-11 |
| Evaluating the Efficacy and Safety of of HSK44459 in Patients With Behçet's Disease (NCT06902428) | Haisco Pharmaceutical Group Co., Ltd. | 2025-03-24 |
| A Phase III Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Naive to Complement Inhibitor Therapy (NCT06799546) | Haisco Pharmaceutical Group Co., Ltd. | 2025-02-13 |
| Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of HSK39004 Dry Powder Inhalation (NCT06971198) | Haisco Pharmaceutical Group Co., Ltd. | 2025-02-10 |
| Evaluating the Efficacy and Safety of of HSK44459 in People With Idiopathic Pulmonary Fibrosis (NCT06764862) | Haisco Pharmaceutical Group Co., Ltd. | 2025-01-17 |
| A Study to Evaluate the Accuracy of aTCI Model of Cipepofol in Patients With General Anesthesia During Elective Surgery (NCT06740201) | Haisco Pharmaceutical Group Co., Ltd. | 2025-01-06 |
| Long-term Safety and Tolerability of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria (NCT06745622) | Haisco Pharmaceutical Group Co., Ltd. | 2025-01-03 |
| Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer (NCT07007910) | Haisco Pharmaceutical Group Co., Ltd. | 2024-12-18 |
| Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects (NCT07134478) | Haisco Pharmaceutical Group Co., Ltd. | 2024-10-28 |
| A Study to Evaluate the Efficacy and Safety of HSK31858 Tablets in Patients with Bronchial Asthma (NCT06637254) | Haisco Pharmaceutical Group Co., Ltd. | 2024-10-22 |
| Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN (NCT06670352) | Haisco Pharmaceutical Group Co., Ltd. | 2024-10-12 |
| A Study to Assess the Efficacy and Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis (NCT06660992) | Haisco Pharmaceutical Group Co., Ltd. | 2024-09-30 |
| A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment in Orthopedic Surgery (NCT07442877) | Haisco Pharmaceutical Group Co., Ltd. | 2024-09-13 |
| Study on Mass Balance of [14C]HSK39297 in Healthy Chinese Adult Male Subjects (NCT06852092) | Haisco Pharmaceutical Group Co., Ltd. | 2024-09-09 |
| Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Primary Efficacy of HSK39004 Suspension for Inhalation (NCT06905847) | Haisco Pharmaceutical Group Co., Ltd. | 2024-09-02 |
| A Phase I Study to Assess the Safety,Tolerability, PK, PD, and Food Effect of HSK44459 in Healthy Subjects (NCT06858657) | Haisco Pharmaceutical Group Co., Ltd. | 2024-08-17 |
| A Study to Evaluate the Efficacy and Safety of HSK39297 in Patients With Paroxysmal Nocturnal Hemoglobinuria（PNH） (NCT06561841) | Haisco Pharmaceutical Group Co., Ltd. | 2024-07-17 |
| Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation (NCT06536400) | Haisco Pharmaceutical Group Co., Ltd. | 2024-06-25 |
| Efficacy and Safety of HSK16149 Capsule in the Treatment of Moderate and Severe Central Neuropathic Pain in China (NCT06422117) | Haisco Pharmaceutical Group Co., Ltd. | 2024-05-30 |
| Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin (NCT06490484) | Haisco Pharmaceutical Group Co., Ltd. | 2024-04-19 |
| A Multicenter, Open, Controlled, Phase III Clinical Study to Evaluate the Efficacy and Safety of Cipepofol Injection for General Anesthesia in Pediatric Patients Undergoing Elective Surgery (NCT06391931) | Haisco Pharmaceutical Group Co., Ltd. | 2024-04-07 |
| A Study on Switching From Daily DPP-4 Inhibitor to HSK7653 in Type 2 Diabetes Patients (NCT06703268) | Haisco Pharmaceutical Group Co., Ltd. | 2024-01-15 |
| To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) . (NCT06168383) | Haisco Pharmaceutical Group Co., Ltd. | 2024-01-05 |
| A Study to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients With COPD (NCT06643078) | Haisco Pharmaceutical Group Co., Ltd. | 2023-12-11 |
| Metabolism and Excretory of HSK21542 in Maintenance Hemodialysis Patients (NCT06238388) | Haisco Pharmaceutical Group Co., Ltd. | 2023-10-10 |
| To Evaluate the Efficacy and Safety of HSK16149 With L-carnitine in Diabetic Peripheral Neuralgia Patients in China (NCT06122012) | Haisco Pharmaceutical Group Co., Ltd. | 2023-05-01 |
| Study of HSK31679 in Subjects With Hypercholesterolemia With Nonalcoholic Fatty Liver Disease（NAFLD） (NCT05795517) | Haisco Pharmaceutical Group Co., Ltd. | 2023-04-26 |
| A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal Impairment (NCT05947097) | Haisco Pharmaceutical Group Co., Ltd. | 2023-04-24 |
| Phase I Study of HSK40118 in NSCLC Patients With EGFR Mutation (NCT06050980) | Haisco Pharmaceutical Group Co., Ltd. | 2023-03-27 |
| The Drug-drug Interaction of HSK16149 Capsule With Probenecid Tablets or Cimetidine Tablets in Healthy Subjects (NCT05881811) | Haisco Pharmaceutical Group Co., Ltd. | 2023-03-20 |
| HSK16149 for Perioperative Analgesia in Orthopedic Surgery (NCT06007066) | Haisco Pharmaceutical Group Co., Ltd. | 2023-03-08 |
| To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Herpetic Neuralgia (NCT05763550) | Haisco Pharmaceutical Group Co., Ltd. | 2023-02-27 |
| A Study to Evaluate the Pharmacokinetics of HSK16149 in Subjects With Renal Impairment (NCT05916573) | Haisco Pharmaceutical Group Co., Ltd. | 2022-12-12 |
| A Study of HSK31858 in Participants with Non-Cystic Fibrosis Bronchiectasis (NCT05601778) | Haisco Pharmaceutical Group Co., Ltd. | 2022-12-06 |
| A Clinical Study to Evaluate the Efficacy, Safety and PK/PD Profiles of Anticoagulation of HSK36273 for Injection in Continuous Renal Replacement Therapy Subjects (NCT05602129) | Haisco Pharmaceutical Group Co., Ltd. | 2022-11-01 |
| A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment (NCT05497297) | Haisco Pharmaceutical Group Co., Ltd. | 2022-08-04 |
| A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients with Chronic Kidney Disease-Associated Pruritus (NCT05135390) | Haisco Pharmaceutical Group Co., Ltd. | 2022-06-17 |
| Relative Bioavailability and Pharmacodynamics of HSK7653 in Healthy Volunteers (NCT06003088) | Haisco Pharmaceutical Group Co., Ltd. | 2022-06-15 |
| A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients for Postoperative Pain Treatment (NCT05390905) | Haisco Pharmaceutical Group Co., Ltd. | 2022-06-08 |
| A Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Dosed of HSK36273 in Healthy Volunteers (NCT05742126) | Haisco Pharmaceutical Group Co., Ltd. | 2022-04-11 |
| Safety, Tolerability,PK/PD, Food Effect of Single and Multiple Ascending Doses of HSK31858 in Healthy Volunteers (NCT05663593) | Haisco Pharmaceutical Group Co., Ltd. | 2022-02-23 |
| Ascending Single-Dose and Multiple-Dose Study to Evaluate HSK31679 in Healthy Subjects and Subjects With Elevated LDL-C (NCT05531097) | Haisco Pharmaceutical Group Co., Ltd. | 2022-02-22 |
| To Evaluate the Long-term Safety and Efficacy of HSK16149 in Chinese Patients With Peripheral Neuralgia (NCT05890053) | Haisco Pharmaceutical Group Co., Ltd. | 2022-02-17 |
| A Trial to Evaluate the Safety and Efficacy of HL231 Solution for Inhalation in Patients with COPD (NCT06619210) | Haisco Pharmaceutical Group Co., Ltd. | 2022-01-12 |
| Drug-drug Interaction Between Ciprofol and Mefanamic Acid or Valproate (NCT05181007) | Haisco Pharmaceutical Group Co., Ltd. | 2021-12-17 |
| To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Postherpetic Neuralgia (NCT05140863) | Haisco Pharmaceutical Group Co., Ltd. | 2021-11-01 |
| A Study of Safety, Tolerability, and Pharmacokinetics of Single Ascending Dosed of HSK31858 in Healthy Volunteers (NCT05023525) | Haisco Pharmaceutical Group Co., Ltd. | 2021-10-28 |
| A Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of HSK21542 Injection in Liver Disease Subjects With Pruritus (NCT04999787) | Haisco Pharmaceutical Group Co., Ltd. | 2021-09-16 |
| Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoing TAVR (NCT05035069) | Haisco Pharmaceutical Group Co., Ltd. | 2021-09-03 |
| A Study of HSK29116 in Adults With Relapsed/Refractory B-cell Malignancies (NCT04861779) | Haisco Pharmaceutical Group Co., Ltd. | 2021-08-24 |
| Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK21542 in Healthy Adult Male Volunteers. (NCT05835934) | Haisco Pharmaceutical Group Co., Ltd. | 2021-06-15 |
| A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride Tablets (NCT04841720) | Haisco Pharmaceutical Group Co., Ltd. | 2021-04-01 |
| HSK7653 in Chinese Patients with Impaired Glucose Tolerance (NCT04727580) | Haisco Pharmaceutical Group Co., Ltd. | 2021-03-29 |
| A Clinical Study to Evaluate Efficacy and Safety of HSK21542 for Postoperative Analgesia of Subjects Undergoing Elective Laparoscopic Surgery Under General Anesthesia (NCT04738357) | Haisco Pharmaceutical Group Co., Ltd. | 2021-03-24 |
| A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical Ventilation (NCT04669821) | Haisco Pharmaceutical Group Co., Ltd. | 2021-03-09 |
| Safety, Tolerability and Pharmacokinetics of FTP-198 Tablet in Healthy Chinese Volunteers (NCT04687813) | Haisco Pharmaceutical Group Co., Ltd. | 2020-12-23 |
| To Evaluate the Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain (NCT04647773) | Haisco Pharmaceutical Group Co., Ltd. | 2020-12-02 |
| A Study to Evaluate the Efficacy and Safety of HSK3486 in the Induction of General Anesthesia (NCT04511728) | Haisco Pharmaceutical Group Co., Ltd. | 2020-11-24 |
| Bioequivalence Study of Ranolazine Extended-release Tablets in Healthy Chinese Subjects (NCT07054255) | Haisco Pharmaceutical Group Co., Ltd. | 2020-09-06 |
| A Study Evaluating the Efficacy and Safety of HSK21542 Injection for Analgesia in Subjects Undergoing Colonoscopy (NCT04470128) | Haisco Pharmaceutical Group Co., Ltd. | 2020-08-19 |
| A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of HSK21542 Injection in Subjects Undergoing Hemodialysis (NCT04470154) | Haisco Pharmaceutical Group Co., Ltd. | 2020-08-10 |
| Study of Acetyllevocarnitine Hydrochloride Tablets in Chinese Patients With Paresthesias Caused by DPN (NCT05319275) | Haisco Pharmaceutical Group Co., Ltd. | 2020-07-23 |
| Bioequivalence Study of Lidocaine and Prilocaine Cream in Healthy Chinese Subjects (NCT07551713) | Haisco Pharmaceutical Group Co., Ltd. | 2020-06-11 |